Amazon.com Inc. (NASDAQ:AMZN) has launched online pharmacy and drug delivery services in Japan, expanding its presence in the company's global healthcare industry.
What Happened: Amazon has launched online prescription and medicine delivery services in Japan, in collaboration with approximately 2,500 drug stores nationwide. This initiative, introduced on Tuesday, will allow consumers to obtain their medications without visiting a physical pharmacy, reported Japan Today.
The Amazon Pharmacy service, already available outside Japan, enables consumers to receive electronic prescriptions after an online diagnosis through the CLINICS comprehensive healthcare app, or at a hospital or clinic. This service is primarily targeted at individuals with chronic health conditions who regularly require prescription refills.
Users of the service can receive guidance on medication administration through video chats with pharmacists, accessed via their Amazon accounts. They can also choose to have their medications delivered to their homes or pick them up from nearby pharmacies.
The Amazon Japan executive expressed the company's commitment to providing personalized healthcare services and plans to collaborate with more pharmacies, including small- and medium-sized ones.
Why It Matters: This recent development in Japan follows Amazon's expansion of its RxPass subscription service to over 50 million Medicare beneficiaries in the U.S. This expansion aimed to provide affordable access to medications for a broader audience.
Amazon's pharmacy unit has been making significant strides, including a partnership with Eli Lilly and Co. for the delivery of obesity drugs. This partnership marked a significant step in expanding access to vital medications, with Amazon Pharmacy becoming a third-party dispensing provider for LillyDirect Pharmacy Solutions.
However, Amazon's foray into the pharmaceutical industry was not without its challenges. The company had to implement major job cuts in its One Medical and Pharmacy units to save $100 million. Despite this, Amazon's pharmacy unit has continued to expand its services, with the recent launch in Japan being a significant step in its global expansion.
Price Action: Amazon's stock closed at $186.41 on Tuesday, up 2.11% for the day. In pre-market trading, the stock is slightly dipped by 0.059%. Year to date, Amazon's stock has risen by $36.48, reflecting a significant increase of 24.33%, according to data from Benzinga Pro.
- AMC Entertainment Announces Restructuring Of Debt Load, Adam Aron Says Box Office Challenges Are In 'Rearview Mirror'
Image Via Shutterstock
This story was generated using Benzinga Neuro and edited by Kaustubh Bagalkote
亞馬遜公司(納斯達克:AMZN)在日本推出了在線藥房和藥品送貨服務,擴大了其在該公司全球醫療保健行業板塊的存在。
發生了什麼事:亞馬遜在日本與全國約2500家藥店合作推出了在線處方和藥品送貨服務。據日本今日消息報道,這項計劃於週二推出,將允許消費者在不到實體藥房的情況下獲得藥物。
亞馬遜藥房服務已在日本以外推出,消費者可以通過CLINICS綜合醫療應用或在醫院或診所經過在線診斷後獲得電子處方。該服務主要針對長期需要處方補充的患者。
服務的用戶可以通過與藥劑師的視頻聊天來獲得有關藥物管理的指導,並通過其亞馬遜帳戶訪問。他們還可以選擇將他們的藥物送到家裏或從附近的藥店取走。
亞馬遜日本的高管表示,該公司致力於提供個性化的醫療保健服務,並計劃與更多的藥店(包括中小型藥店)合作。
在美國,亞馬遜將其RxPass訂閱服務擴展到了超過5000萬名醫保受益人。這個擴展旨在爲更廣泛的觀衆提供負擔得起的藥物。在日本的這一最新進展之前,亞馬遜已經在醫療保健行業板塊取得了重要的進展。
亞馬遜的藥房部門已經取得了重大進展,包括與禮來公司合作提供肥胖症藥物的交付服務。這一合作標誌着擴大獲得重要藥物的途徑邁出了重要一步,亞馬遜藥房成爲LillyDirect Pharmacy Solutions的第三方配藥供應商。
然而,亞馬遜進軍制藥業並不是沒有挑戰的。該公司不得不在One Medical和Pharmacy部門實施重大裁員以節省1億美元。儘管如此,亞馬遜的藥房部門仍在不斷擴展其服務,最近在日本的推出是其全球拓展的重大一步。
價格行動:週二,亞馬遜的股票收於186.41美元,上漲了2.11%。在美股盤前交易中,該股票略有下跌,下跌了0.059%,根據Benzinga Pro的數據,亞馬遜的股票今年以來已經上漲了36.48美元,反映了顯着的漲幅24.33%。
- amc院線宣佈重組債務負擔,Adam Aron表示票房挑戰已經是過去式。
圖片來自shutterstock
本報道使用Benzinga Neuro生成,並由Kaustubh Bagalkote